Skip to main content
. 2018 Feb;7(1):132–144. doi: 10.21037/tau.2017.12.29

Figure 4.

Figure 4

Number of positive MRIs with Gleason score outcome of MRI-targeted biopsies, stratified to PI-RADS and PSA-density. Blue: beneficial outcome of the test results, stratified to PI-RADS and PSA-density; light red: low detection of clinically significant prostate cancer, stratified to PI-RADS and PSA-density; red: high detection of clinically significant prostate cancer, stratified to PI-RADS and PSA-density. MRI, MRI, magnetic resonance imaging; PSA, prostate specific antigen.